Ceftazidime (INN) ( /sɛfˈtæzɨdiːm/) is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa, however it has weaker activity against Gram-positive microorganisms and is not used for such infections. Ceftazidime pentahydrate is marketed under various trade names including Cefzim (Pharco B International), Fortum (GSK), and Fortaz.

Read more about CeftazidimeClinical Use, Chemistry

Other articles related to "ceftazidime":

Ceftazidime - Chemistry
... The extra stability to β-lactamases increases the activity of ceftazidime against otherwise resistant Gram-negative organisms including Pseudomonas aeruginosa ...
Melioidosis - Treatment - Current Treatment
... Intravenous ceftazidime is the current drug of choice for treatment of acute melioidosis ... meropenem is currently being tested with ceftazidime in a Thai clinical trial (ATOM) ... concentration for imipenem is lower than for ceftazidime ...